|
SMN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92589999947756E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85389999995955E-06 |
| Normal-vs-Stage2 |
4.819400E-03 |
| Normal-vs-Stage3 |
2.987100E-04 |
| Normal-vs-Stage4 |
9.73079999999626E-05 |
| Stage1-vs-Stage2 |
9.329600E-01 |
| Stage1-vs-Stage3 |
5.664800E-01 |
| Stage1-vs-Stage4 |
6.683200E-01 |
| Stage2-vs-Stage3 |
6.572800E-01 |
| Stage2-vs-Stage4 |
8.137800E-01 |
| Stage3-vs-Stage4 |
3.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42479999967848E-07 |
| Normal-vs-AfricanAmerican |
1.450220E-02 |
| Normal-vs-Asian |
3.953200E-04 |
| Caucasian-vs-AfricanAmerican |
5.274000E-01 |
| Caucasian-vs-Asian |
2.158200E-01 |
| AfricanAmerican-vs-Asian |
1.505440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.93540000043613E-07 |
| Normal-vs-Female |
3.94859999996999E-06 |
| Male-vs-Female |
8.630600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.304800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.22050000000019E-05 |
| Normal-vs-Age(61-80Yrs) |
2.7514999945133E-08 |
| Normal-vs-Age(81-100Yrs) |
5.514100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.240800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.528800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.191500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.063800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.293570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.105900E-02 |
| Normal-vs-Grade 2 |
1.36010000040265E-07 |
| Normal-vs-Grade 3 |
5.79119999999378E-05 |
| Normal-vs-Grade 4 |
2.442300E-03 |
| Grade 1-vs-Grade 2 |
8.030600E-01 |
| Grade 1-vs-Grade 3 |
8.479200E-01 |
| Grade 1-vs-Grade 4 |
9.106400E-01 |
| Grade 2-vs-Grade 3 |
2.071800E-01 |
| Grade 2-vs-Grade 4 |
4.480400E-01 |
| Grade 3-vs-Grade 4 |
8.921000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.02939999980079E-07 |
| Normal-vs-ccB subtype |
2.614900E-04 |
| ccA subtype-vs-ccB subtype |
4.478200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.32960000027205E-07 |
| Normal-vs-N1 |
1.131160E-01 |
| N0-vs-N1 |
4.344800E-01 |
|
|
